Long-term Effects of Metformin on Diabetes Prevention: Identification of Subgroups That Benefited Most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study

Primary Prevention
DOI: 10.2337/dc18-1970 Publication Date: 2019-03-15T19:11:46Z
AUTHORS (287)
ABSTRACT
We examined the effects of metformin on diabetes prevention and subgroups that benefited most over 15 years in Diabetes Prevention Program (DPP) its follow-up, Outcomes Study (DPPOS).During DPP (1996-2001), adults at high risk developing were randomly assigned to masked placebo (n = 1,082) or 850 mg twice daily 1,073). Participants originally continued receive metformin, unmasked, DPPOS (2002-present). Ascertainment development was based fasting 2-h glucose levels after an oral tolerance test HbA1c. Reduction incidence with compared by hazard ratio (HR) rate differences (RDs).During postrandomization reduced (by HR) 17% 36% HbA1c levels, respectively. Metformin's effect glucose-defined greater for women a history prior gestational mellitus (GDM) (HR 0.59, RD -4.57 cases/100 person-years) parous without GDM 0.94, -0.38 person-years [interaction P 0.03 HR, 0.01 RD]). Metformin also had effects, HR RD, higher baseline levels. With HbA1c, more effective subjects -1.03 <6.0% (42 mmol/mol) -3.88 6.0-6.4% (P 0.0001).Metformin reduces years. The subsets benefitted include GDM.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (18)
CITATIONS (96)